These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 3928727)
21. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients. Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368 [TBL] [Abstract][Full Text] [Related]
22. Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia. Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD J Am Coll Cardiol; 1987 Feb; 9(2):398-404. PubMed ID: 3805529 [TBL] [Abstract][Full Text] [Related]
23. Ventricular arrhythmias: use of electrophysiologic studies. Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834 [TBL] [Abstract][Full Text] [Related]
24. Amiodarone treatment of critical arrhythmias in children and young adults. Garson A; Gillette PC; McVey P; Hesslein PS; Porter CJ; Angell LK; Kaldis LC; Hittner HM J Am Coll Cardiol; 1984 Oct; 4(4):749-55. PubMed ID: 6384328 [TBL] [Abstract][Full Text] [Related]
25. Predictive value of early electrophysiologic testing in determining long-term outcome with amiodarone treatment in patients with sustained ventricular tachycardia. Shannon JA; Hammill SC; Gersh BJ Mayo Clin Proc; 1991 Nov; 66(11):1114-9. PubMed ID: 1943242 [TBL] [Abstract][Full Text] [Related]
26. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552 [TBL] [Abstract][Full Text] [Related]
27. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal. Lavery D; Saksena S Am Heart J; 1987 Jan; 113(1):49-56. PubMed ID: 3799441 [TBL] [Abstract][Full Text] [Related]
28. The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia. Morgera T; Dreas L; Humar F; Maras P; Chersevani D; Camerini F Int J Cardiol; 1991 May; 31(2):187-97. PubMed ID: 1869328 [TBL] [Abstract][Full Text] [Related]
29. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy. Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388 [TBL] [Abstract][Full Text] [Related]
30. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy. Veltri EP; Reid PR; Platia EV; Griffith LS J Am Coll Cardiol; 1985 Oct; 6(4):806-13. PubMed ID: 3928726 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone. Manolis AS; Uricchio F; Estes NA Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375 [TBL] [Abstract][Full Text] [Related]
32. Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart. Shenasa M; Denker S; Mahmud R; Lehmann M; Estrada A; Akhtar M J Am Coll Cardiol; 1984 Jul; 4(1):105-10. PubMed ID: 6736436 [TBL] [Abstract][Full Text] [Related]
34. Amiodarone: correlation of early and late electrophysiologic studies with outcome. Kadish AH; Marchlinski FE; Josephson ME; Buxton AE Am Heart J; 1986 Dec; 112(6):1134-40. PubMed ID: 3788759 [TBL] [Abstract][Full Text] [Related]
35. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia. Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093 [TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia. Saksena S; Rothbart ST; Shah Y; Cappello G Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016 [TBL] [Abstract][Full Text] [Related]
37. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia. Nademanee K; Hendrickson J; Kannan R; Singh BN Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035 [No Abstract] [Full Text] [Related]
38. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone. Calkins H; Sousa J; el-Atassi R; Schmaltz S; Kadish A; Morady F J Am Coll Cardiol; 1992 Feb; 19(2):347-52. PubMed ID: 1732363 [TBL] [Abstract][Full Text] [Related]